Empowered Funds LLC boosted its position in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 11.4% in the second quarter, Holdings Channel reports. The fund owned 18,166 shares of the insurance provider’s stock after acquiring an additional 1,864 shares during the period. Empowered Funds LLC’s holdings in Allstate were worth $3,657,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Arlington Trust Co LLC increased its stake in shares of Allstate by 261.8% in the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 89 shares during the period. Clearstead Trust LLC grew its holdings in Allstate by 3,800.0% in the 2nd quarter. Clearstead Trust LLC now owns 156 shares of the insurance provider’s stock valued at $31,000 after buying an additional 152 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in Allstate by 315.0% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock valued at $33,000 after buying an additional 126 shares during the last quarter. Hilltop National Bank bought a new position in Allstate in the 2nd quarter worth approximately $34,000. Finally, Chilton Capital Management LLC acquired a new position in shares of Allstate during the second quarter worth approximately $38,000. 76.47% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Allstate news, insider Suren Gupta sold 400 shares of the company’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $215.22, for a total value of $86,088.00. Following the sale, the insider directly owned 100,646 shares in the company, valued at $21,661,032.12. This represents a 0.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.70% of the stock is currently owned by corporate insiders.
Allstate Trading Up 1.2%
Allstate (NYSE:ALL – Get Free Report) last posted its earnings results on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share for the quarter, beating analysts’ consensus estimates of $5.48 by $5.69. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The business had revenue of $17.26 billion for the quarter, compared to analysts’ expectations of $16.59 billion. During the same quarter in the previous year, the firm posted $3.91 earnings per share. The firm’s revenue for the quarter was up 3.8% on a year-over-year basis. On average, equities research analysts forecast that The Allstate Corporation will post 18.74 earnings per share for the current fiscal year.
Allstate Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Monday, December 1st will be given a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Monday, December 1st. Allstate’s dividend payout ratio (DPR) is 12.95%.
Analyst Ratings Changes
Several brokerages have recently issued reports on ALL. JPMorgan Chase & Co. raised their price objective on shares of Allstate from $254.00 to $260.00 and gave the stock an “overweight” rating in a research note on Thursday, November 6th. Wall Street Zen downgraded shares of Allstate from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 8th. Evercore ISI set a $233.00 price target on shares of Allstate and gave the stock an “in-line” rating in a research report on Wednesday, October 1st. Roth Capital set a $230.00 price objective on shares of Allstate and gave the company a “buy” rating in a research report on Friday, September 26th. Finally, Cantor Fitzgerald upgraded shares of Allstate to a “hold” rating in a research note on Wednesday, August 13th. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $237.64.
Check Out Our Latest Stock Analysis on ALL
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- Conference Calls and Individual Investors
- MP Materials Stock Soared After Earnings—Here’s the Real Reason
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Why Palantir Slide May Be a Setup for a Long-Term Opportunity
- How to buy stock: A step-by-step guide for beginners
- Attention Income Investors: This REIT Is on Sale
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
